U.S. markets closed
  • S&P 500

    4,326.51
    -23.42 (-0.54%)
     
  • Dow 30

    34,160.78
    -7.31 (-0.02%)
     
  • Nasdaq

    13,352.78
    -189.34 (-1.40%)
     
  • Russell 2000

    1,931.29
    -45.18 (-2.29%)
     
  • Crude Oil

    87.10
    -0.25 (-0.29%)
     
  • Gold

    1,794.30
    -35.40 (-1.93%)
     
  • Silver

    22.75
    -1.06 (-4.44%)
     
  • EUR/USD

    1.1148
    -0.0097 (-0.86%)
     
  • 10-Yr Bond

    1.8070
    -0.0410 (-2.22%)
     
  • GBP/USD

    1.3383
    -0.0080 (-0.59%)
     
  • USD/JPY

    115.3600
    +0.7000 (+0.61%)
     
  • BTC-USD

    35,648.86
    -1,455.75 (-3.92%)
     
  • CMC Crypto 200

    808.12
    -11.39 (-1.39%)
     
  • FTSE 100

    7,554.31
    +84.53 (+1.13%)
     
  • Nikkei 225

    26,170.30
    -841.03 (-3.11%)
     

Xtant Medical to Present at the H.C. Wainwright 23rd Annual Global Investment Conference

  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • XTNT

BELGRADE, Mont., Sept. 07, 2021 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that Sean Browne, Chief Executive Officer, will present at the H.C. Wainwright 23rd Annual Global Investment Conference to be held September 13 - 15, 2021.

A pre-recorded presentation will be available on the Investors section of the Company’s website at www.xtantmedical.com, or by clicking here, beginning on Monday, September 13, 2021 at 7:00 AM Eastern Time. The presentation will be accessible for 90 days.

About Xtant Medical Holdings, Inc.

Xtant Medical Holdings, Inc. (www.xtantmedical.com) is a global medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Xtant people are dedicated and talented, operating with the highest integrity to serve our customers.

The symbols ™ and ® denote trademarks and registered trademarks of Xtant Medical Holdings, Inc. or its affiliates, registered as indicated in the United States, and in other countries. All other trademarks and trade names referred to in this release are the property of their respective owners.

Investor Relations Contact

David Carey
Lazar FINN
Ph: 212-867-1762
Email: david.carey@finnpartners.com

126030756.2